Search research articles
Contact Us
Filters
Showing results (1-10 of 104) with videos related to
Page
of 11
Sort By:
Presse Medicale (Paris, France : 1983)
|
July 24, 2013
[New oral anticoagulant pharmacology]
Xavier Delavenne
Pharmaceutics
|
October 23, 2021
Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition
Sonia Saib, Xavier Delavenne
Therapie
|
December 24, 2014
[Direct oral anticoagulant, useful pharmacological characteristics in clinical practice]
Edouard Ollier, Xavier Delavenne
Thrombosis Research
|
May 26, 2020
Pharmacokinetics for haemophilia treaters: Meaning of PK parameters, interpretation pitfalls, and use in the clinic
Xavier Delavenne, Yesim Dargaud
Revue Medicale Suisse
|
March 15, 2014
[New oral anticoagulants: pharmacological data to know for clinical practice]
Xavier Delavenne, Silvy Laporte, Patrick Mismetti
European Journal of Drug Metabolism and Pharmacokinetics
|
July 9, 2017
Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?
Clément Mercier, Nathalie Perek, Xavier Delavenne
The European Respiratory Journal
|
April 2, 2013
Antithrombotics in pulmonary hypertension: more work needed before we turn to newer agents!
Laurent Bertoletti, Xavier Delavenne, David Montani
Journal of Pharmaceutical and Biomedical Analysis
|
March 19, 2013
Rapid determination of apixaban concentration in human plasma by liquid chromatography/tandem mass spectrometry: application to pharmacokinetic study
Xavier Delavenne, Patrick Mismetti, Thierry Basset
British Journal of Clinical Pharmacology
|
January 12, 2019
Dose tailoring of human cell line-derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia A
Xavier Delavenne, Yesim Dargaud, Edouard Ollier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 27, 2020
A new paradigm for personalized prophylaxis for patients with severe haemophilia A
Xavier Delavenne, Edouard Ollier, Anne Lienhart, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 104) with videos related to
Sort By:
Page
of 11
Presse Medicale (Paris, France : 1983)
|
July 24, 2013
[New oral anticoagulant pharmacology]
Xavier Delavenne
Pharmaceutics
|
October 23, 2021
Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition
Sonia Saib, Xavier Delavenne
Therapie
|
December 24, 2014
[Direct oral anticoagulant, useful pharmacological characteristics in clinical practice]
Edouard Ollier, Xavier Delavenne
Thrombosis Research
|
May 26, 2020
Pharmacokinetics for haemophilia treaters: Meaning of PK parameters, interpretation pitfalls, and use in the clinic
Xavier Delavenne, Yesim Dargaud
Revue Medicale Suisse
|
March 15, 2014
[New oral anticoagulants: pharmacological data to know for clinical practice]
Xavier Delavenne, Silvy Laporte, Patrick Mismetti
European Journal of Drug Metabolism and Pharmacokinetics
|
July 9, 2017
Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?
Clément Mercier, Nathalie Perek, Xavier Delavenne
The European Respiratory Journal
|
April 2, 2013
Antithrombotics in pulmonary hypertension: more work needed before we turn to newer agents!
Laurent Bertoletti, Xavier Delavenne, David Montani
Journal of Pharmaceutical and Biomedical Analysis
|
March 19, 2013
Rapid determination of apixaban concentration in human plasma by liquid chromatography/tandem mass spectrometry: application to pharmacokinetic study
Xavier Delavenne, Patrick Mismetti, Thierry Basset
British Journal of Clinical Pharmacology
|
January 12, 2019
Dose tailoring of human cell line-derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia A
Xavier Delavenne, Yesim Dargaud, Edouard Ollier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 27, 2020
A new paradigm for personalized prophylaxis for patients with severe haemophilia A
Xavier Delavenne, Edouard Ollier, Anne Lienhart, et al.
Page
of 11